BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25173869)

  • 1. The function and regulation of mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Shu X; Pei D
    Curr Opin Genet Dev; 2014 Oct; 28():32-7. PubMed ID: 25173869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Esteban MA; Bao X; Zhuang Q; Zhou T; Qin B; Pei D
    Curr Opin Genet Dev; 2012 Oct; 22(5):423-8. PubMed ID: 23084025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitions between epithelial and mesenchymal states during cell fate conversions.
    Li X; Pei D; Zheng H
    Protein Cell; 2014; 5(8):580-91. PubMed ID: 24805308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT and MET as paradigms for cell fate switching.
    Chen J; Han Q; Pei D
    J Mol Cell Biol; 2012 Apr; 4(2):66-9. PubMed ID: 22140271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
    Chen T; You Y; Jiang H; Wang ZZ
    J Cell Physiol; 2017 Dec; 232(12):3261-3272. PubMed ID: 28079253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routes to induced pluripotent stem cells.
    Ruetz T; Kaji K
    Curr Opin Genet Dev; 2014 Oct; 28():38-42. PubMed ID: 25198100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells.
    Kovacic B; Rosner M; Schipany K; Ionce L; Hengstschläger M
    Eur J Clin Invest; 2015 Apr; 45(4):415-22. PubMed ID: 25646864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell reprogramming into the pluripotent state using graphene based substrates.
    Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
    Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal-epithelial transition in development and reprogramming.
    Pei D; Shu X; Gassama-Diagne A; Thiery JP
    Nat Cell Biol; 2019 Jan; 21(1):44-53. PubMed ID: 30602762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KGF and BMP-6 intervene in cellular reprogramming and in mesenchymal-epithelial transition (MET) of 3T3L1 mouse adipose cells.
    Reza AM; Lee S; Shiwani S; Singh NK
    Cell Biol Int; 2015 Apr; 39(4):400-10. PubMed ID: 25492426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of microRNA in cell reprogramming].
    Stepniewski J; Józkowicz A; Dulak J
    Postepy Biochem; 2013; 59(2):157-63. PubMed ID: 24044280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial to mesenchymal transition as a portal to stem cell characters embedded in gene networks.
    Asli NS; Harvey RP
    Bioessays; 2013 Mar; 35(3):191-200. PubMed ID: 22987504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming by lineage specifiers: blurring the lines between pluripotency and differentiation.
    Sancho-Martinez I; Ocampo A; Izpisua Belmonte JC
    Curr Opin Genet Dev; 2014 Oct; 28():57-63. PubMed ID: 25461451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
    Sanges D; Cosma MP
    Int J Dev Biol; 2010; 54(11-12):1575-87. PubMed ID: 21305473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular reprogramming by transcription factor engineering.
    Tsang JC; Gao X; Lu L; Liu P
    Curr Opin Genet Dev; 2014 Oct; 28():1-9. PubMed ID: 25151337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic reprogramming of somatic cells into neuroblasts through a co-induction of the doublecortin gene along the Yamanaka factors: A promising approach to model neuroregenerative disorders.
    Kandasamy M; Yesudhas A; Poornimai Abirami GP; Radhakrishnan RK; Roshan SA; Johnson E; Ravichandran VR; Biswas A; Shanmugaapriya S; Anusuyadevi M; Aigner L
    Med Hypotheses; 2019 Jun; 127():105-111. PubMed ID: 31088631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
    Sanges D; Lluis F; Cosma MP
    Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of pluripotent stem cells via protein transduction.
    Li X; Zhang P; Wei C; Zhang Y
    Int J Dev Biol; 2014; 58(1):21-7. PubMed ID: 24860991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular reprogramming--lowering gravity on Waddington's epigenetic landscape.
    Takahashi K
    J Cell Sci; 2012 Jun; 125(Pt 11):2553-60. PubMed ID: 22736045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.